Key result
Fenofibrate and intravenous insulin infusion reduced triglyceride levels by 81% (from 58.8 to 11 mmol/L) by day 7 in a pregnant woman with acute pancreatitis, resulting in a healthy delivery.
Why the study?
Hypertriglyceridemia is associated with a high risk of developing acute pancreatitis in pregnant women, but the condition is rare.
Case Report (n=1)
No
Intravenous insulin and fenofibrate successfully and safely reduced severe hypertriglyceridemia and resolved acute pancreatitis in a pregnant patient.
May support fenofibrate plus insulin for triglyceride control in pregnant pancreatitis; hypothesis-generating, requiring prospective validation.
Introduction Hypertriglyceridemia (HTG) (triglycerides > 1,000 mg/dL [11.3 mmol/L]) has been associated with a high risk of developing acute pancreatitis (AP) in pregnant women, but this condition is rare. We present the case of a pregnant Saudi with AP secondary to HTG. Case Report A 27-year-old Saudi female presented at 30 weeks' gestational age with abdominal pain, nausea, and vomiting of 4 days' duration. AP was diagnosed based on clinical presentation, high lipase, and abdominal ultrasound findings. Her triglyceride level was 58 mmol/L. Fenofibrate and intravenous regular insulin infusion with dextrose were started, which decreased triglycerides by the third day from 58.8 to 29 mmol/L (50% reduction) with a further reduction to 11 mmol/L (81%) by day 7 of her admission. Labor was induced at 37 weeks of gestation, and she delivered a healthy neonate. Conclusion We report successful treatment of AP in pregnancy with intravenous insulin and fenofibrate. Several case reports have discussed the therapeutic option of AP induced by HTG in pregnancy. Lipid-lowering agents are category C in pregnancy. However, few case reports indicate their safety. Insulin, heparin, and apheresis have also been used during pregnancy without any complications.
No takes yet. Share an insight, caveat, or question.
Alenezi et al. (2022) conducted a case report in Acute pancreatitis secondary to hypertriglyceridemia (n=1). Fenofibrate and intravenous regular insulin infusion with dextrose was evaluated on Triglyceride level reduction. Fenofibrate and intravenous insulin infusion reduced triglyceride levels by 81% (from 58.8 to 11 mmol/L) by day 7 in a pregnant woman with acute pancreatitis, resulting in a healthy delivery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: